Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model.
Kenta NakaoAtsushi FujiwaraNobuyasu KomasawaDenan JinManabu KitanoSayuri MatsunamiShinji TakaiSeiji ItoToshiaki MinamiPublished in: Evidence-based complementary and alternative medicine : eCAM (2019)
Bone cancer pain control is difficult because it includes various characteristics of pain such as nociceptic and neuropathic pain. In this study, we investigated the effect of yokukansan (YKS), one of the traditional Japanese herbal medicines, on cancer pain in mouse bone metastasis model. Oral administration of YKS significantly alleviated pain behavior measured by quantitative body weight bearing. Furthermore, the pain behavior was also significantly alleviated by intrathecal and intraperitoneal administration of matrix metalloproteinase- (MMP-) 9 inhibitor, but not of MMP-2 inhibitor. MMP-9 expression was significantly elevated in the bone tissue on day 3 after carcinoma cell injection and in the ipsilateral spinal cord on day 7, which was suppressed by YKS administration. Taken together, these results suggest that YKS alleviates cancer pain via suppressing MMP-9 expression in bone metastasis model in mice.
Keyphrases
- neuropathic pain
- chronic pain
- spinal cord
- pain management
- spinal cord injury
- papillary thyroid
- bone mineral density
- poor prognosis
- squamous cell
- soft tissue
- signaling pathway
- metabolic syndrome
- bone loss
- young adults
- mass spectrometry
- ultrasound guided
- atomic force microscopy
- postoperative pain
- skeletal muscle
- single molecule